At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Anamed OEM device; Air Next mobile spirometry devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Proof-of-concept, Open-label, Feasibility Study to Evaluate Mobile Applications and Biosensing (mHealth) Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms/COPD
In Brief
An observational study evaluating Anamed OEM device; Air Next mobile spirometry device for Signs and Symptoms, Respiratory and 3 related conditions. Completed, enrolled 27 participants across 1 site.
Detailed Summary
This study examines the feasibility and acceptability of using mobile applications and biosensing (mHealth) devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate, blood oxygenation, steps/motion) for a future big-scale study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSigns and Symptoms, Respiratory, Mobile Applications, Activity Trackers, Respiratory Function Tests
CountriesKazakhstan
CollaboratorsPhilip Morris International, Synergy Research Group
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJun 2019
First PostedSep 2019
Primary CompletionOct 2019
Study CompletionOct 2019
TodayJul 2026
First PostedSep 9, 2019
Enrollment StartJun 7, 2019
Primary CompletionOct 10, 2019
Study CompletionOct 31, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.8 years ago
Interventions
Anamed OEM device; Air Next mobile spirometry devicedevice
Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device